S-8 1 tmb-20210301xs8.htm S-8

As filed with the Securities and Exchange Commission on March 1, 2021

Registration No. 333-              

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________

FORM S-8

REGISTRATION STATEMENT

UNDER THE

SECURITIES ACT OF 1933

________________

MORPHIC HOLDING, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

47-3878772

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification Number)

35 Gatehouse Drive, A2

Waltham, Massachusetts 02451

(781) 996-0955

(Address, including zip code, and telephone number, including area code, of Registrant’s principal executive offices)

2019 Equity Incentive Plan

2019 Employee Stock Purchase Plan

(Full title of the plans)

Praveen P. Tipirneni, M.D.

President and Chief Executive Officer

Morphic Holding, Inc.

35 Gatehouse Drive, A2

Waltham, Massachusetts 02451

(781) 996-0955

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Please send copies of all communications to:

Effie Toshav, Esq.

Robert Freedman, Esq.

Julia Forbess, Esq.


Fenwick & West LLP
555 California Street, 12th Floor

San Francisco, California 94104
(415) 875-2300

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

Non-accelerated filer

 

  

  

Smaller reporting company

 

 

  

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  

 


CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities

to be Registered

Amount to be

Registered(1)

Proposed Maximum

Offering Price

Per Share

Proposed Maximum

Aggregate Offering

Price

Amount of

Registration

Fee

Common Stock, par value $0.0001 per share

-- 2019 Equity Incentive Plan

1,285,547(2)

$ 34.07 (3)

$43,798,587

$4,779

-- 2019 Employee Stock Purchase Plan

321,386(4)

$ 28.95 (5)

$9,304,125

$1,016

Total

1,606,933

$53,102,712

$5,795

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that becomes issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.

(2)

Represents additional shares to be registered and available for grant under the 2019 Equity Incentive Plan (“2019 EIP”) resulting from the annual 4% automatic increase in the number of authorized shares available for issuance under the 2019 EIP.

(3)

Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $34.07 was computed by averaging the high and low prices of a share of Registrant’s common stock as reported on The Nasdaq Global Market on February 23, 2021.

(4)

Represents additional shares to be registered and available for grant under the 2019 ESPP resulting from the annual 1% automatic increase in the number of authorized shares available for issuance under the 2019 ESPP.

(5)

Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $28.95 was computed by averaging the high and low prices of a share of Registrant’s common stock as reported on The Nasdaq Global Market on February 23, 2021, multiplied by 85%, which is the percentage of the trading price per share applicable to purchasers under the 2019 ESPP.


REGISTRATION OF ADDITIONAL SHARES

PURSUANT TO GENERAL INSTRUCTION E

 

Morphic Holding, Inc. (the “Registrant”) is filing this Registration Statement with the Securities and Exchange Commission (the “Commission”) to register (a) 1,285,547 additional shares of common stock available for issuance under the Registrant’s 2019 EIP, pursuant to the provision of the 2019 EIP providing for an annual 4% automatic increase in the number of shares reserved for issuance and (b) 321,386 additional shares of common stock available for issuance under the Registrant’s 2019 ESPP, pursuant to the provision of the 2019 ESPP providing for an annual 1% automatic increase in the number of shares reserved for issuance.

 

In accordance with General Instruction E of Form S-8, and only with respect to the common stock issuable under the 2019 EIP and 2019 ESPP, this Registration Statement hereby incorporates by reference the contents of the Registrant’s Registration Statements on Form S-8 filed with the Commission on June 27, 2019 (Registration No. 333-232372) and on February 27, 2020 (Registration No. 333-236727), to the extent not superseded hereby.


PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant with the Commission pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are incorporated herein by reference:

(a)

the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Commission on March 1, 2021 pursuant to Section 13 of the Exchange Act;

(b)

all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the Registrant’s Annual Report on Form 10-K referred to in (a) above; and

(c)

The description of the Registrant’s common stock contained in the Registrant’s registration statement on Form 8-A (File No. 001-38940) filed on June 14, 2019 under Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

All documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such documents as set forth therein. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement.

Item 5. Interests of Named Experts and Counsel.

Not applicable.

Item 8. Exhibits.

The following exhibits are filed herewith:

Exhibit

​ ​ Incorporated by Reference​ ​​ ​

Filed

Number

Exhibit Description

Form

File No.

Exhibit

Filing Date

Herewith

4.1

Restated Certificate of Incorporation of the Registrant

10-Q

001-38940

3.1

8/13/2019

4.2

Restated Bylaws of the Registrant as amended

10-Q

001-38940

3.2

5/6/2020

4.3

Form of Registrant’s Common Stock certificate

S-1/A

333-231837

4.1

6/14/2019

5.1

Opinion of Fenwick & West LLP

X

23.1

Consent of Fenwick & West LLP (contained in Exhibit 5.1)

X

23.2

Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm

X

24.1

Power of Attorney (included on the signature page to this Registration Statement)

X

99.1

2019 Equity Incentive Plan and forms of award agreements thereunder

S-1/A

333-231837

10.3

6/14/2019

99.2

2019 Employee Stock Purchase Plan and forms of award agreements thereunder

S-1/A

333-231837

10.4

6/14/2019


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Waltham, Commonwealth of Massachusetts, on this 1st day of March, 2021.

MORPHIC HOLDING, INC.

By:

/s/ Praveen Tipirneni

Praveen Tipirneni

President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Praveen P. Tipirneni and William D. DeVaul, and each of them, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Name

Title

Date

    

    

/s/ Praveen Tipirneni

Praveen Tipirneni

President, Chief Executive Officer and Director

(Principal Executive Officer)

March 1, 2021

/s/ Marc Schegerin, M.D.

Marc Schegerin

Chief Financial Officer and Chief Operating Officer (Principal Financial Officer)

March 1, 2021

/s/ Robert E. Farrell, Jr.

Robert E. Farrell, Jr., CPA

Chief Accounting Officer

(Principal Accounting Officer)

March 1, 2021

/s/ Gustav Christensen

Gustav Christensen

Director

March 1, 2021

/s/ Norbert Bischofberger

Norbert Bischofberger

Director

March 1, 2021

/s/ Martin Edwards

Martin Edwards

Director

March 1, 2021

/s/ Vikas Goyal

Vikas Goyal

Director

March 1, 2021

/s/ Nilesh Kumar, Ph.D.

Nilesh Kumar

Director

March 1, 2021

/s/ Amir Nashat

Amir Nashat

Director

March 1, 2021


/s/ Timothy A. Springer, Ph.D.

Director

March 1, 2021

Timothy A. Springer, Ph.D

/s/ Joseph P. Slattery

Joseph P. Slattery

Director

March 1, 2021

/s/ Otello Stampacchia

Otello Stampacchia

Director

March 1, 2021